Jpmorgan Chase & CO Ice Cure Medical Ltd. Put Options Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ICCM
# of Institutions
13Shares Held
100KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA25.6KShares$18,9140.0% of portfolio
-
Hrt Financial LP New York, NY18.7KShares$13,8570.0% of portfolio
-
Kingdom Financial Group Llc. Peoria, AZ15.3KShares$11,2850.01% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ15.3KShares$11,2850.0% of portfolio
-
Foundations Investment Advisors, LLC10KShares$7,4000.0% of portfolio
About IceCure Medical Ltd.
- Ticker ICCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,835,600
- Market Cap $27.3M
- Description
- IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.